The U.S. Food and Drug Administration warned CVS, Walgreens and other companies that they violated federal law by marketing unapproved eye products.
The eye products are being illegally marketed as being able to treat cataracts, glaucoma, conjunctivitis and more. The FDA said some of the eye products are labeled to contain silver and long-term use can cause skin and body tissues, including the eye, to permanently turn gray or blue-gray.
The companies have 15 days to respond to the FDA's warning letter as it continues its investigation.
The FDA issued warning letters for specific eye drops at the following companies:
This year, multiple eye products were recalled for causing harm to people, including blindness, infections and sometimes death.
In February, EzriCare Artificial tears were voluntarily recalled by the manufacturer after receiving 55 reports of eye infection, blindness and a death caused by a bloodstream infection. The India-based Global Pharma Healthcare, later issued another recall due to possible contamination. The eye drops, which were linked to a drug-resistant germ pseudomonas aeruginosa, resulted in four deaths, according to the Centers for Disease Control and Prevention.
By March, Pharmedica USA LLC and Apotex Corp. pulled eyedrops off the shelves for potential lack of sterility. In August, the FDA warned consumers not to purchase and immediately stop using Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops-Eye Repair due to contamination.
2 more eye drop products recalledafter being linked to potentially deadly bacteria
Recalled contaminated eye dropslinked to bacteria have led to a fourth death, CDC says
2024-12-25 01:38284 view
2024-12-25 01:37776 view
2024-12-25 00:34784 view
2024-12-24 23:42626 view
2024-12-24 23:332738 view
2024-12-24 23:292730 view
Veteran journalist and news anchor Chris Wallace is leaving CNN after more than two years at the cab
Isabella Strahan is commemorating a belated milestone.Michael Strahan's daughter recently spent the
TOKYO (AP) — Asian shares were mostly lower Wednesday after a mixed session on Wall Street following